MOBI
Mobia Medical, Inc.
Company overview
- Market capitalization
- $293.96M
- Employees
- 167
- Latest publication
- 2026-09-29
About Mobia Medical, Inc.
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Total Revenue | 13,505,000USD |
| Cost Of Revenue | 2,267,000USD |
| Gross Profit | 11,238,000USD |
| Research Development | 2,278,000USD |
| Selling General Administrative | 26,886,000USD |
| Total Operating Expenses | 29,164,000USD |
| Operating Income | -17,926,000USD |
| Total Other Income Expense Net | -3,115,000USD |
| Interest Expense | 254,000USD |
| Income Before Tax | -21,041,000USD |
| Income Tax Expense | 2,000USD |
| Net Income | -21,043,000USD |
| Net Income Applicable To Common Shares | -21,043,000USD |
| Source | DisclosureDeterministicFinal |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD |
|---|---|---|
| Total Revenue | 32,040,978USD | 15,644,398USD |
| Cost Of Revenue | 6,065,955USD | 3,193,173USD |
| Gross Profit | 25,975,023USD | 12,451,225USD |
| Research Development | 6,515,249USD | 4,243,399USD |
| Selling General Administrative | 65,827,675USD | 32,444,116USD |
| Unclassified Operating Expenses | 6,065,955USD | 3,193,173USD |
| Total Operating Expenses | 78,408,879USD | 39,880,688USD |
| Operating Income | -46,367,901USD | -24,236,290USD |
| Interest Expense | 967,368USD | 969,920USD |
| Net Interest Income | -967,368USD | -969,920USD |
| Income Before Tax | -46,492,738USD | -24,589,101USD |
| Tax Provision | 5,450USD | 13,913USD |
| Net Income | -46,498,188USD | -24,603,014USD |
| Net Income From Continuing Ops | -46,498,188USD | -24,603,014USD |
| Reconciled Depreciation | 151,657USD | 116,010USD |
| Total Other Income Expense Net | 842,531USD | 617,109USD |
| Source | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Total Assets | 195,284,000USD |
| Cash And Equivalents | 177,090,000USD |
| Total Current Assets | 192,149,000USD |
| Other Current Assets | 2,446,000USD |
| Other Non Current Assets | 143,000USD |
| Total Liabilities | 22,675,000USD |
| Total Current Liabilities | 14,472,000USD |
| Total Stockholder Equity | 172,609,000USD |
| Total Equity Including Noncontrolling Interest | 172,609,000USD |
| Net Receivables | 5,664,000USD |
| Inventory | 6,949,000USD |
| Property Plant Equipment Net | 2,992,000USD |
| Accounts Payable | 2,359,000USD |
| Short Term Debt | 358,000USD |
| Common Stock | 333,000USD |
| Retained Earnings | -196,572,000USD |
| Source | DisclosureDeterministicFinal |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD |
|---|---|---|
| Total Assets | 48,148,699USD | 22,091,037USD |
| Other Current Assets | 1,942,958USD | 299,023USD |
| Total Liab | 198,922,286USD | 128,126,840USD |
| Total Stockholder Equity | -150,773,587USD | -106,035,803USD |
| Other Current Liab | 1,323,498USD | 499,534USD |
| Capital Stock | 8,840USD | 7,767USD |
| Retained Earnings | -157,789,133USD | -111,290,945USD |
| Cash | 33,587,308USD | 14,620,320USD |
| Total Current Assets | 46,357,242USD | 21,174,741USD |
| Total Current Liabilities | 10,206,207USD | 4,596,806USD |
| Long Term Debt | 7,129,928USD | 7,094,070USD |
| Net Receivables | 4,435,223USD | 2,826,236USD |
| Inventory | 5,456,757USD | 3,429,162USD |
| Accounts Payable | 2,222,970USD | 1,139,326USD |
| Property Plant Equipment Net | 1,737,582USD | 894,964USD |
| Property Plant Equipment Gross | 2,041,987USD | 1,120,933USD |
| Common Stock Shares Outstanding | 33,085,391shares | 33,085,391shares |
| Non Current Assets Total | 1,791,457USD | 916,296USD |
| Non Current Liabilities Total | 188,716,079USD | 123,530,034USD |
| Non Currrent Assets Other | 53,875USD | 21,332USD |
| Net Working Capital | 36,151,035USD | 16,577,935USD |
| Unclassified Current Liabilities | 6,659,739USD | 2,957,946USD |
| Unclassified Non Current Liabilities | 181,586,151USD | 116,435,964USD |
| Unclassified Equity | 7,006,706USD | 5,247,375USD |
| Source | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD |
|---|---|---|
| Net Income | -46,498,188USD | -24,603,014USD |
| Depreciation | 151,657USD | 116,010USD |
| Stock Based Compensation | 1,446,702USD | 758,127USD |
| Other Non Cash Items | 270,474USD | 48,297USD |
| Change To Account Receivables | -1,608,987USD | -1,386,950USD |
| Change To Inventory | -2,027,595USD | -245,409USD |
| Change In Working Capital | -923,683USD | -634,721USD |
| Total Cash From Operating Activities | -45,694,990USD | -24,315,301USD |
| Capital Expenditures | -364,411USD | -40,848USD |
| Free Cash Flow | -46,059,401USD | -24,356,149USD |
| Total Cash From Financing Activities | 65,026,389USD | 15,658,269USD |
| Issuance Of Capital Stock | 64,712,687USD | 14,986,642USD |
| Change In Cash | 18,966,988USD | -8,697,880USD |
| Begin Period Cash Flow | 14,620,320USD | 23,318,200USD |
| End Period Cash Flow | 33,587,308USD | 14,620,320USD |
| Source | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.